I have a fair value range of $450-$530 per share. Ok, now your turn to post your valuation workings.
- Forums
- ASX - By Stock
- Ann: REA Group Q1 FY2015 financial information released
I have a fair value range of $450-$530 per share. Ok, now your...
-
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add REA (ASX) to my watchlist
(20min delay)
|
|||||
Last
$204.33 |
Change
2.890(1.43%) |
Mkt cap ! $26.99B |
Open | High | Low | Value | Volume |
$203.14 | $205.81 | $201.46 | $21.80M | 106.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 327 | $204.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$204.33 | 447 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 327 | 204.070 |
1 | 107 | 203.950 |
1 | 327 | 203.900 |
1 | 327 | 203.730 |
1 | 674 | 203.720 |
Price($) | Vol. | No. |
---|---|---|
204.450 | 352 | 1 |
204.610 | 283 | 1 |
204.770 | 1000 | 1 |
204.890 | 327 | 1 |
204.960 | 107 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
REA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online